asa.biopharm.01

Sponsor(s): Sponsoring Section/Society: ASA-Biopharm

Session Time: 10:30-12:20 Tuesday

Estimated Audience Size: 200-250

A/V Request: two overheads

Session Title: Formal Design Considerations for Phase I Clinical Trials

Theme Session: No $\quad$ Applied Session: no

Organizer: Rosenberger, William F.  

Session Timing: Opening Remarks by Chair - 5 minutes First Speaker - 25 minutes Second Speaker - 25 minutes Third Speaker - 25 minutes Discussant - 15 minutes Floor Discusion - 15 minutes

Chair: Rosenberger, William F.  

1. Designing Studies for Dose-Response $\quad$ Wong, Weng Ke  

2. Ehrenfest Urn Designs for Quantile Estimation $\quad$ Flournoy, Nancy  

$\quad$ Durham, Stephen  

3. Dose Escalation Schemes for Cancer Phase I Trials $\quad$ Zacks, Shelemyahu  

Discussant: Ting, Naitee  

List of speakers who are nonmembers: None